Home › Targets › TGFβ

TGFβ (1 companies · 2 programs)

Companies with an active program directed at TGFβ.

Agomab Therapeutics NV AGMB

ontunisertib — Fibrostenotic Crohn's Disease Phase 2
AGMB-447 — Idiopathic Pulmonary Fibrosis Phase 1